These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16762586)

  • 41. Women's needs for CAM information to manage menopausal symptoms.
    Armitage GD; Suter E; Verhoef MJ; Bockmuehl C; Bobey M
    Climacteric; 2007 Jun; 10(3):215-24. PubMed ID: 17487648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change.
    Gerend MA; Aiken LS; Erchull MJ; Lapin A
    Prev Med; 2006 Sep; 43(3):158-64. PubMed ID: 16750263
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The general practitioner's view on hormone replacement therapy during and after menopause].
    Gjelsvik B; Swensen E; Hjortdahl P
    Tidsskr Nor Laegeforen; 2007 May; 127(11):1500-3. PubMed ID: 17551553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.
    Verkooijen HM; Bouchardy C; Vinh-Hung V; Rapiti E; Hartman M
    Maturitas; 2009 Oct; 64(2):80-5. PubMed ID: 19709827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hormone replacement Up-to-date. Menopause in women and hormone replacement therapy (HRT). Indications for HRT in postmenopausal women].
    Ohta H
    Clin Calcium; 2007 Sep; 17(9):1315-24. PubMed ID: 17767019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spanish post-menopausal women's viewpoints on hormone therapy.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
    Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current trends in hormone replacement therapy: perceptions and usage.
    Birkhäuser MH; Reinecke I
    Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hormone replacement therapy menopause with a better future--a survey of views on hormone replacement therapy (HRT).
    Shafi S; Samad Z; Syed S; Sharif A; Khan MA; Nehal US; Siddiqui AR
    J Pak Med Assoc; 2001 Dec; 51(12):450-3. PubMed ID: 11850984
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormone replacement therapy: attitude and acceptance of Bangkokian women.
    Taechakraichana N; Wilawan K; Wipatavit V; Maitrisathit S; Thamanavat N; Jaisamrarn U; Panyakhamlerd K; Havanond P; Limpaphayom KK
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S385-98. PubMed ID: 12930015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S
    Maturitas; 2006 Nov; 55(4):308-16. PubMed ID: 16730140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scottish gynaecologists: their views on hormone replacement therapy.
    Campbell-Brown M; McEwan HP
    Health Bull (Edinb); 1992 May; 50(3):248-51. PubMed ID: 1506194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions between melatonin and estrogen may regulate cerebrovascular function in women: clinical implications for the effective use of HRT during menopause and aging.
    Harrod CG; Bendok BR; Hunt Batjer H
    Med Hypotheses; 2005; 64(4):725-35. PubMed ID: 15694689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hormonal management of migraine at menopause.
    Nappi RE; Sances G; Detaddei S; Ornati A; Chiovato L; Polatti F
    Menopause Int; 2009 Jun; 15(2):82-6. PubMed ID: 19465675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Age fifty and menopause. Complaints expressed and unexpressed by women. Practitioners' perception and therapeutic impact].
    Jamin C; Leutenegger E; Senoussi S; Devaux C
    Gynecol Obstet Fertil; 2005 Mar; 33(3):119-25. PubMed ID: 15848083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project.
    Lundberg V; Tolonen H; Stegmayr B; Kuulasmaa K; Asplund K;
    Maturitas; 2004 May; 48(1):39-49. PubMed ID: 15223107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perspective on hormone therapy 10 years after the WHI.
    Ghazal S; Pal L
    Maturitas; 2013 Nov; 76(3):208-12. PubMed ID: 24094493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.